GlycoMimetics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $10 |
Gross Profit | -12 | -14 | -13 | |
EBITDA | -5,713 | -10,345 | -11,100 | -9,567 |
EBIT | -5,721 | -10,357 | -11,115 | -9,590 |
Net Income | -9,824 | -10,095 | -10,736 | -9,079 |
Net Change In Cash | 0 | 0 | 0 | 10 |
Free Cash Flow | -7,994 | -8,895 | -10,516 | -7,615 |
Cash | 14,391 | 22,386 | 31,281 | 41,792 |
Basic Shares | 64,483 | 64,483 | 64,457 | 64,393 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $10 | $74 | $1,160 | $10,163 |
Gross Profit | 10 | 74 | 1,160 | 10,163 |
EBITDA | -39,121 | -47,195 | -63,182 | -51,238 |
EBIT | -39,275 | -47,403 | -63,447 | -51,509 |
Net Income | -36,899 | -93,328 | -63,142 | -50,274 |
Net Change In Cash | 10 | 74 | 1,160 | 10,163 |
Cost of Revenue | -21,166 | |||
Free Cash Flow | -34,901 | -46,541 | -57,504 | -39,310 |
Cash | 41,792 | 47,871 | 90,255 | 137,035 |
Basic Shares | 63,342 | 52,531 | 51,453 | 45,721 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.15 |
2024-06-30 | -$0.16 |
2024-03-31 | -$0.17 |
2023-12-31 | -$0.14 |
